Evaluation of hepcidin-25/erythroferrone ratio as a potential biomarker for iron utility and erythropoiesis responsiveness to erythropoiesis-stimulating therapy in comparison to immature erythrocyte/reticulocyte parameters in hemodialysis patients

Background: Anemia-associated chronic kidney disease increases in more advanced stages with a subsequent acceleration in renal impairment progressing to end-stage renal disease. Although hepcidin and erythroferrone have been described as novel biomarkers of iron metabolism, there is still an area of...

詳細記述

書誌詳細
出版年:Hematology, Transfusion and Cell Therapy
主要な著者: Salwa Bakr, Karem Mohamed Salem, Ahmed Mohammed Rashed, Mohamed E A Tantawy, Asmaa Younis Elsary, Hanan Abdelmoneam Shamardl, Eman Mahmoud Ezzat
フォーマット: 論文
言語:英語
出版事項: Elsevier 2024-11-01
主題:
オンライン・アクセス:http://www.sciencedirect.com/science/article/pii/S2531137924003006

類似資料